Fennec Pharmaceuticals (FRX.TO) Q1 2025 Earnings

10MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.3
-0.01
0.27
0.56

Details

Expected EPS
-0.18555564189660398
Actual EPS
-0.08681668716092399
Surprise EPS
0.1
Surprise Percent
+53.21%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.08681668716092399 per share for Q1 2025.

0 Comments

Share your thoughts